Optimization of factor VIII replacement therapy: can structural studies help in evading antibody inhibitors?
about
The tertiary structure and domain organization of coagulation factor VIIIThe IL-10 polarized cytokine pattern in innate and adaptive immunity cells contribute to the development of FVIII inhibitors.The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfacesSurface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities.Cytokine profile and FVIII inhibitors development in haemophilia A.
P2860
Optimization of factor VIII replacement therapy: can structural studies help in evading antibody inhibitors?
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Optimization of factor VIII re ...... n evading antibody inhibitors?
@ast
Optimization of factor VIII re ...... n evading antibody inhibitors?
@en
Optimization of factor VIII re ...... n evading antibody inhibitors?
@nl
type
label
Optimization of factor VIII re ...... n evading antibody inhibitors?
@ast
Optimization of factor VIII re ...... n evading antibody inhibitors?
@en
Optimization of factor VIII re ...... n evading antibody inhibitors?
@nl
prefLabel
Optimization of factor VIII re ...... n evading antibody inhibitors?
@ast
Optimization of factor VIII re ...... n evading antibody inhibitors?
@en
Optimization of factor VIII re ...... n evading antibody inhibitors?
@nl
P2860
P1476
Optimization of factor VIII re ...... n evading antibody inhibitors?
@en
P2093
Barry L Stoddard
P Clint Spiegel
P2860
P304
P356
10.1046/J.1365-2141.2002.03845.X
P407
P577
2002-11-01T00:00:00Z